BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 26292957)

  • 1. Serum markers of CYFRA 21-1 and C-reactive proteins in oral squamous cell carcinoma.
    Hsu YP; Hsieh CH; Chien HT; Lai CH; Tsao CK; Liao CT; Kang CJ; Wang HM; Chang JT; Huang SF
    World J Surg Oncol; 2015 Aug; 13():253. PubMed ID: 26292957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk stratification in oral cavity squamous cell carcinoma by preoperative CRP and SCC antigen levels.
    Huang SF; Wei FC; Liao CT; Wang HM; Lin CY; Lo S; Huang JJ; Chen IH; Kang CJ; Chien HT; Chen HH
    Ann Surg Oncol; 2012 Nov; 19(12):3856-64. PubMed ID: 22576068
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Roles of SCC Antigen, CRP and CYFRA 21-1 in Oral Cavity Squamous Cell Carcinoma.
    DE Paz D; Young CK; Chien HT; Tsao CK; Fok CC; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
    Anticancer Res; 2019 Apr; 39(4):2025-2033. PubMed ID: 30952746
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of serum C-reactive protein (CRP) and cytokeratin 19 fragments (Cyfra 21-1) but not carcinoembryonic antigen (CEA) in surgically treated patients with non-small cell lung cancer.
    Szturmowicz M; Rudziński P; Kacprzak A; Langfort R; Bestry I; Broniarek-Samson B; Orłowski T
    Pneumonol Alergol Pol; 2014; 82(5):422-9. PubMed ID: 25133810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of serum Cyfra 21-1 in patients with primary oral squamous cell carcinoma.
    Zhong LP; Zhu HG; Zhang CP; Chen WT; Zhang ZY
    Int J Oral Maxillofac Surg; 2007 Mar; 36(3):230-4. PubMed ID: 16965897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Refining the role of preoperative C-reactive protein by neutrophil/lymphocyte ratio in oral cavity squamous cell carcinoma.
    Fang HY; Huang XY; Chien HT; Chang JT; Liao CT; Huang JJ; Wei FC; Wang HM; Chen IH; Kang CJ; Huang SF
    Laryngoscope; 2013 Nov; 123(11):2690-9. PubMed ID: 23619955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum Cyfra 21-1 levels in oral squamous cell carcinoma patients and its clinicopathologic correlation.
    Singh P; Barpande SR; Bhavthankar JD; Mandale MS; Bhagwat AU
    Indian J Dent Res; 2017; 28(2):162-168. PubMed ID: 28611326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salivary and serum level of CYFRA 21-1 in oral precancer and oral squamous cell carcinoma.
    Rajkumar K; Ramya R; Nandhini G; Rajashree P; Ramesh Kumar A; Nirmala Anandan S
    Oral Dis; 2015 Jan; 21(1):90-6. PubMed ID: 24304502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Roles of preoperative C-reactive protein are more relevant in buccal cancer than other subsites.
    Tai SF; Chien HT; Young CK; Tsao CK; de Pablo A; Fan KH; Liao CT; Wang HM; Kang CJ; Chang JT; Huang SF
    World J Surg Oncol; 2017 Feb; 15(1):47. PubMed ID: 28209200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
    Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
    Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation of Cyfra 21-1 levels in saliva and serum with CK19 mRNA expression in oral squamous cell carcinoma.
    Malhotra R; Urs AB; Chakravarti A; Kumar S; Gupta VK; Mahajan B
    Tumour Biol; 2016 Jul; 37(7):9263-71. PubMed ID: 26779624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Usefulness of the SCC, CEA, CYFRA 21.1, and CRP markers for the diagnosis and monitoring of cervical squamous cell carcinoma].
    Chmura A; Wojcieszek A; Mrochem J; Walaszek-Gruszka A; Deja R; Masłyk B; Bartnik W; Sodowski K
    Ginekol Pol; 2009 May; 80(5):361-6. PubMed ID: 19548456
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follow-up with serum Cyfra 21-1 in patients with squamous cell carcinomas of the head and neck.
    Kuropkat C; Lippert BM; Werner JA
    Oncology; 2002; 63(3):280-5. PubMed ID: 12381908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative SCC Antigen, CRP Serum Levels, and Lymph Node Density in Oral Squamous Cell Carcinoma.
    Adel M; Tsao CK; Wei FC; Chien HT; Lai CH; Liao CT; Wang HM; Fan KH; Kang CJ; Chang JT; Huang SF
    Medicine (Baltimore); 2016 Apr; 95(14):e3149. PubMed ID: 27057838
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Diagnostic and Prognostic Value of Tumor Markers (CEA, SCC, CYFRA 21-1, TPS) in Head and Neck Cancer Patients.
    Barak V; Meirovitz A; Leibovici V; Rachmut J; Peretz T; Eliashar R; Gross M
    Anticancer Res; 2015 Oct; 35(10):5519-24. PubMed ID: 26408719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum SCCA, Cyfra 21-1, EGFR and Cyclin D1 levels in patients with oral squamous cell carcinoma.
    Feng XY; Li JH; Li JZ; Han ZX; Xing RD
    Int J Biol Markers; 2010; 25(2):93-8. PubMed ID: 20586028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical significance of preoperative squamous cell carcinoma antigen in oral-cavity squamous cell carcinoma.
    Lin WH; Chen IH; Wei FC; Huang JJ; Kang CJ; Hsieh LL; Wang HM; Huang SF
    Laryngoscope; 2011 May; 121(5):971-7. PubMed ID: 21520110
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using SCC antigen and CRP levels as prognostic biomarkers in recurrent oral cavity squamous cell carcinoma.
    Chen IH; Liao CT; Wang HM; Huang JJ; Kang CJ; Huang SF
    PLoS One; 2014; 9(7):e103265. PubMed ID: 25061977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combination of serum tumor markers identifies high-risk patients with early-stage squamous cervical cancer.
    Davelaar EM; van de Lande J; von Mensdorff-Pouilly S; Blankenstein MA; Verheijen RH; Kenemans P
    Tumour Biol; 2008; 29(1):9-17. PubMed ID: 18497544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of serum CYFRA 21-1 1 in patients with anal canal squamous cell carcinoma treated with radio(chemo)therapy.
    Gauthé M; Richard-Molard M; Rigault E; Buecher B; Mariani P; Bellet D; Cacheux W; Lièvre A
    BMC Cancer; 2018 Apr; 18(1):417. PubMed ID: 29653564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.